Research Study
View Full Study →
Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophrenia.
Citation
Radin D., Cerne R., Smith J., Witkin J., Lippa A. (2025). Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophrenia.. J Psychiatr Res. DOI: 10.1016/j.jpsychires.2025.04.019
Abstract
Abstract not available. See citation for source.
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.